EXOGEN IS A PROUD
SPONSOR OF SPARTAN
Approved by the US Food and Drug Administration (FDA): In just 20 minutes a day at home, EXOGEN accelerates the healing of indicated fresh fractures and repair of fractures that failed to heal on their own.*1-3
One in every 20 bone fractures fails to heal properly6
...and many fractures may take longer to heal than expected. EXOGEN can help.
Heal rate of common fractures at risk for nonunions.†8 LEARN MORE >
Patient Success Story
With his season on the line, former All-Pro tight end Greg Olsen used EXOGEN to get back on the field
The above video story is representative of a US FDA-approved indication for the use of EXOGEN.
Disclaimer: Information presented in patient testimonials is representative of a specific patient experience only and is not medical advice. Patients are compensated for providing testimonials. Individual responses may vary.
Summary of Indications for Use
The EXOGEN Ultrasound Bone Healing System is indicated for the non-invasive treatment of established nonunions* excluding skull and vertebra. The EXOGEN device has also been reported as effective as an adjunctive non-invasive treatment of established nonunions in patients:
- With internal or external fracture fixation hardware present. EXOGEN cannot penetrate metal and therefore should not be applied directly over hardware.
- Undergoing treatment for infection at the fracture site. EXOGEN is not intended to treat the infection.
- Believed to have diminished bone quality. EXOGEN is not intended to treat diminished bone quality.
In addition, EXOGEN is indicated for accelerating the time to a healed fracture for fresh, closed, posteriorly displaced distal radius fractures and fresh, closed or Grade I open tibial diaphysis fractures in skeletally mature individuals when these fractures are orthopedically managed by closed reduction and cast immobilization.
There are no known contraindications for the EXOGEN device. Safety and effectiveness have not been established for individuals lacking skeletal maturity, pregnant or nursing women, patients with cardiac pacemakers, on fractures due to bone cancer, or on patients with poor blood circulation or clotting problems. Some patients may be sensitive to the ultrasound gel.
*A nonunion is considered to be established when the fracture site shows no visibly progressive signs of healing.
Full prescribing information can be found in product labelling, at EXOGEN.com, or by calling Customer Service at 1-800-836-4080.